SCHEMBL5304396

SCHEMBL5304396

CN(C)C(=O)c1cccc2nc3ccccc3cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 5/20 0.47
HPGD P15428 3/20 0.47
GLA P06280 3/20 0.47
POLB P06746 2/20 0.47
NPC1 O15118 1/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47
PTBP1 P26599 1/20 0.47
RAB9A P51151 1/20 0.47
RCE1 Q9Y256 1/20 0.47
TP53 P04637 3/20 0.46
CYP3A4 P08684 2/20 0.46
HIF1A Q16665 2/20 0.46
CYP2D6 P10635 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
PDE10A Q9Y233 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29043320 0.82 ALDH1A1 (0.51) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL222908 0.82 NR4A1 (0.60) KMT2AMEN1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL27356901 0.82 ALDH1A1 (0.55) KMT2AMEN1ALDH1A1KDM4EHPGD
Acridine SCHEMBL29774329 0.80 NR4A1 (0.58) KMT2AMEN1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL8377331 0.80 ALDH1A1 (0.61) KMT2AMEN1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL5352931 0.80 ALDH1A1 (0.53) KMT2AMEN1SMN1; SMN2ALDH1A1KDM4E
Water SCHEMBL7769203 0.80 NR4A1 (0.58) KMT2AMEN1SMN1; SMN2ALDH1A1KDM4E
Acridine SCHEMBL31147690 0.80 NR4A1 (0.58) KMT2AMEN1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL8850857 0.80 NR4A1 (0.58) KMT2AMEN1SMN1; SMN2ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL9083721 0.80 NR4A1 (0.58) KMT2AMEN1SMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0988068-B1 MEDICAL DEVICES CONTAINING SEGMENTED POLYURETHANE BIOMATERIALS MEDTRONIC INC (US) 2007-09-26 EP disclosed
US-6915168-B1 Medical devices containing segmented polyurethane biomaterials MEDTRONIC, INC. 2005-07-05 US disclosed
EP-0988068-A2 MEDICAL DEVICES CONTAINING SEGMENTED POLYURETHANE BIOMATERIALS Medtronic Inc. (US) 2000-03-29 EP disclosed
WO-1998050086-A2 MEDICAL DEVICES CONTAINING SEGMENTED POLYURETHANE BIOMATERIALS MEDTRONIC, INC. (US) 1998-11-12 WO disclosed
US-5198526-A Heterocycle oligomers with multidimensional morphology THE BOEING COMPANY (US) 1993-03-30 US disclosed
US-5126410-A Solvent resistant polybenzoxazoles, polybenzothiazoles and polybenzimidazoles THE BOEING COMPANY (US) 1992-06-30 US disclosed
US-5120819-A Heat and sovent-resistant polybenzoxazoles,-thiazoles and -imidazoles for aerospace applications BOEING COMPANY (US) 1992-06-09 US disclosed
US-5082905-A Blended heterocycles THE BOEING COMPANY (US) 1992-01-21 US disclosed
EP-0261575-B1 SOLVENT RESISTANT POLYETHERAMIDEIMIDES GENERAL ELECTRIC COMPANY (US) 1991-07-31 EP disclosed
US-4965336-A PHENYLIMIDE ACID HALIDE ENCAPPED POLYBENZOXAZLES; CURABLE, SOLVENT RESISTANCE PREPREGS THE BOEING COMPANY (US) 1990-10-23 US disclosed
EP-0309649-A2 High performance heterocycle oligomers and blends THE BOEING COMPANY (US) 1989-04-05 EP disclosed
US-4794153-A Polyanhydride-siloxanes and polyimide-siloxanes obtained therefrom GENERAL ELECTRIC COMPANY (US) 1988-12-27 US disclosed
US-4742150-A INJECTION MOLDABLE THERMOPLASTIC GENERAL ELECTRIC COMPANY (US) 1988-05-03 US disclosed
EP-0261575-A1 Solvent resistant polyetheramideimides GENERAL ELECTRIC COMPANY (US) 1988-03-30 EP disclosed
US-4544503-A REACTING HYDROXY BENZENESULFONATE WITH CARBON MONOXIDE AND OLEFIN ETHYL CORPORATION (US) 1985-10-01 US disclosed
US-3975345-A ELECTROCOATING GENERAL ELECTRIC COMPANY (US) 1976-08-17 US disclosed